Controlled substance accountability and delayed medication notification failures
Summary
The facility failed to maintain accurate controlled substance records and accountability for hydrocodone-acetaminophen administered to Resident 35. Resident 35 was admitted with dementia and COPD, and had a physician order dated February 9, 2026, for hydrocodone-acetaminophen 5/325 mg every six hours as needed for pain rated 4 through 10. The facility used a Controlled Substance Record and MAR to track receipt, administration, and remaining inventory of controlled medications. A comparison of the Controlled Substance Record and the February 2026 MAR showed that hydrocodone was removed from inventory on eight occasions, but only four administrations were documented on the MAR. The MAR did not document administration for doses removed from inventory on February 2, 2026 at 10:30 AM, February 7, 2026 at 12:33 PM, February 11, 2026 at 1:00 PM, and February 12, 2026 at 9:30 PM. The facility policy required incoming and outgoing nurses to jointly count controlled substances at each shift change and document verification of the count. Observation of the A Hall medication cart on June 14, 2026, at 9:53 AM showed multiple missing signatures on controlled substance shift count records, including numerous dates in March, April, May, and June 2026. The observation also showed the incoming day shift nurse signed the controlled substance count record for both the incoming day shift and the outgoing 11:00 PM shift, documenting verification before the end of the outgoing shift and before the actual shift change. The DON and NHA reviewed these findings and confirmed the facility failed to implement effective procedures to reconcile, monitor, and account for controlled substances administered to Resident 35. The facility also failed to notify the physician when a prescribed medication could not be administered as ordered for Resident 98. Resident 98 was admitted with osteoarthritis and rheumatoid arthritis and was severely cognitively impaired, with a BIMS score of 3 on the April 20, 2026 quarterly MDS. Resident 98 had an order for Prolia (denosumab) to be given on the 22nd day of every sixth month. Nursing progress notes documented that on April 22, 2026, the medication was unavailable, the pharmacy was contacted, and the medication would be delivered with the next pharmacy delivery on April 25, 2026, resulting in a three-day delay. The clinical record did not show that the attending physician was notified of the delay or consulted for alternate instructions, and the DON and NHA confirmed the medication was not available in the pharmacy or emergency supply and had to be ordered.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release August 26, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.